Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Diagnostic Medical SystemsFRA:DMS1 +0.82%66 Cash Ratio is 0.29 as of Dec. 2025, which is 26% above its 10-year median of 0.23. GuruFocus rates FRA:DMS1 with a GF Score™ of 66/100 and a GF Value™ of €1.03 (Fairly Valued). The stock has 4 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Diagnostic Medical Systems ranks worse than 78.72% on this metric.
Diagnostic Medical Systems has a Cash Ratio of 0.29. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Diagnostic Medical Systems's Cash Ratio or its related term are showing as below:
FRA:DMS1'
s Cash Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.23 Max: 0.48
Current: 0.29
During the past 13 years, Diagnostic Medical Systems's highest Cash Ratio was 0.48. The lowest was 0.07. And the median was 0.23.
FRA:DMS1's Cash Ratio is ranked worse than 78.72% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.98
vs FRA:DMS1: 0.29
Diagnostic Medical Systems (FRA:DMS1) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Diagnostic Medical Systems Cash Ratio Related Terms
Diagnostic Medical Systems Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Diagnostic Medical Systems's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (FRA:DMS1) has a Cash Ratio of 0.29 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Diagnostic Medical Systems and its competitors. This is 26% above median its historical median of 0.23. Over the past decade, Diagnostic Medical Systems' Cash Ratio has ranged from 0.07 to 0.48. According to the industry distribution chart, Diagnostic Medical Systems ranks #662 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 78.7%.
Is Diagnostic Medical Systems' Cash Ratio too high?
Diagnostic Medical Systems' current Cash Ratio of 0.29 is 26% above median its 10-year median of 0.23. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.48. The Medical Devices & Instruments industry median Cash Ratio is 0.98. Diagnostic Medical Systems' value of 0.29 is 70.4% below this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #662 out of 841 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Cash Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #662 out of 841 companies for Cash Ratio. This places Diagnostic Medical Systems in the lower half of its industry. The industry median Cash Ratio is 0.98. Diagnostic Medical Systems' value of 0.29 is 70.4% below this benchmark. Historically, Diagnostic Medical Systems' own Cash Ratio has ranged from 0.07 to 0.48 over the past decade. While the company's 10-year median is 0.23 vs. the industry median of 0.98, Diagnostic Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.98, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current Cash Ratio of 0.29 is 70.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current Cash Ratio is 0.29, which is 26% above median its own 10-year median of 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (FRA:DMS1) is currently considered Fairly Valued. The stock's GF Value™ is €1.03, compared to a current price of €0.98 — trading 4.9% below its estimated fair value. The current Cash Ratio is 0.29, which is 26% above median its 10-year median of 0.23 and 70.4% below the Medical Devices & Instruments industry median of 0.98. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Diagnostic Medical Systems (FRA:DMS1), the current Cash Ratio is 0.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (FRA:DMS1) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be undervalued.
The current stock price of €0.98 is trading 4.9% below its estimated GF Value™ of €1.03.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for FRA:DMS1:
Cash Ratio: 0.29 (26% above median its 10-year median of 0.23)
GF Value™: €1.03 vs. price of €0.98 (4.9% below fair value)
Industry Position: 70.4% below the Medical Devices & Instruments median (#662 of 841)
No single metric tells the full story. See the FRA:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score
Get the complete analysis for FRA:DMS1
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMS1 has been successfully added to your 
